804 related articles for article (PubMed ID: 26969270)
1. Awareness of nonalcoholic steatohepatitis and associated practice patterns of primary care physicians and specialists.
Polanco-Briceno S; Glass D; Stuntz M; Caze A
BMC Res Notes; 2016 Mar; 9():157. PubMed ID: 26969270
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic fatty liver disease: a systematic review.
Rinella ME
JAMA; 2015 Jun; 313(22):2263-73. PubMed ID: 26057287
[TBL] [Abstract][Full Text] [Related]
3. Real-life Perception and Practice Patterns of NAFLD/NASH in Romania: Results of a Survey Completed by 102 Board-certified Gastroenterologists.
Iacob S; Ester C; Lita M; Ratziu V; Gheorghe L
J Gastrointestin Liver Dis; 2016 Jun; 25(2):183-9. PubMed ID: 27308649
[TBL] [Abstract][Full Text] [Related]
4. Nonalcoholic steatohepatitis diagnosis and treatment from the perspective of patients and primary care physicians: a cross-sectional survey.
Nadolsky K; Cryer DR; Articolo A; Fisher T; Schneider J; Rinella M
Ann Med; 2023 Dec; 55(1):2211349. PubMed ID: 37171239
[TBL] [Abstract][Full Text] [Related]
5. Continuing to Confront COPD International Physician Survey: physician knowledge and application of COPD management guidelines in 12 countries.
Davis KJ; Landis SH; Oh YM; Mannino DM; Han MK; van der Molen T; Aisanov Z; Menezes AM; Ichinose M; Muellerova H
Int J Chron Obstruct Pulmon Dis; 2015; 10():39-55. PubMed ID: 25565799
[TBL] [Abstract][Full Text] [Related]
6. Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
Spengler EK; Loomba R
Mayo Clin Proc; 2015 Sep; 90(9):1233-46. PubMed ID: 26219858
[TBL] [Abstract][Full Text] [Related]
7. Management of patients with non-alcoholic steatohepatitis (NASH) in real life.
Serfaty L
Liver Int; 2018 Feb; 38 Suppl 1():52-55. PubMed ID: 29427486
[TBL] [Abstract][Full Text] [Related]
8. Nonalcoholic steatohepatitis medical patient journey from the perspective of hepatologists, gastroenterologists and patients: a cross-sectional survey.
Rinella M; Cryer DR; Articolo A; Fisher T; Schneider J; Nadolsky K
BMC Gastroenterol; 2022 Jul; 22(1):335. PubMed ID: 35811319
[TBL] [Abstract][Full Text] [Related]
9. Identifying practice gaps to optimize medical care for patients with nonalcoholic fatty liver disease.
Wieland AC; Quallick M; Truesdale A; Mettler P; Bambha KM
Dig Dis Sci; 2013 Oct; 58(10):2809-16. PubMed ID: 23843097
[TBL] [Abstract][Full Text] [Related]
10. Liver histology and clinical trials for nonalcoholic steatohepatitis-perspectives from 2 pathologists.
Kleiner DE; Bedossa P
Gastroenterology; 2015 Nov; 149(6):1305-8. PubMed ID: 26409177
[No Abstract] [Full Text] [Related]
11. Histopathology of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.
Takahashi Y; Fukusato T
World J Gastroenterol; 2014 Nov; 20(42):15539-48. PubMed ID: 25400438
[TBL] [Abstract][Full Text] [Related]
12. A global survey of health care workers' awareness of non-alcoholic fatty liver disease: The AwareNASH survey.
Driessen S; de Jong VD; van Son KC; Klompenhouwer T; Colardelle Y; Alings M; Moreno C; Anker SD; Castro Cabezas M; Holleboom AG; Grobbee DE; Tushuizen ME
United European Gastroenterol J; 2023 Sep; 11(7):654-662. PubMed ID: 37563849
[TBL] [Abstract][Full Text] [Related]
13. APPROACH TO THE PATIENT WITH NONALCOHOLIC FATTY LIVER DISEASE.
Mikolašević I; Orlić L; Štimac D; Mavrinac V; Colić M; Ostojić D; Milić S
Lijec Vjesn; 2016 May; 138(5-6):159-163. PubMed ID: 29182828
[TBL] [Abstract][Full Text] [Related]
14. Liver fibrosis markers of nonalcoholic steatohepatitis.
Enomoto H; Bando Y; Nakamura H; Nishiguchi S; Koga M
World J Gastroenterol; 2015 Jun; 21(24):7427-35. PubMed ID: 26139988
[TBL] [Abstract][Full Text] [Related]
15. Clinical Presentation and Patient Evaluation in Nonalcoholic Fatty Liver Disease.
Patel V; Sanyal AJ; Sterling R
Clin Liver Dis; 2016 May; 20(2):277-92. PubMed ID: 27063269
[TBL] [Abstract][Full Text] [Related]
16. Nonalcoholic Steatohepatitis: Histopathology Basics Within a Broader Context.
Schild MH; Guy CD
Surg Pathol Clin; 2018 Jun; 11(2):267-285. PubMed ID: 29751874
[TBL] [Abstract][Full Text] [Related]
17. Primary care practitioners survey of non-alcoholic fatty liver disease.
Said A; Gagovic V; Malecki K; Givens ML; Nieto FJ
Ann Hepatol; 2013; 12(5):758-65. PubMed ID: 24018493
[TBL] [Abstract][Full Text] [Related]
18. Clinical and Economic Burden of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis.
Younossi ZM; Henry L; Bush H; Mishra A
Clin Liver Dis; 2018 Feb; 22(1):1-10. PubMed ID: 29128049
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and severity of non-alcoholic fatty liver disease are underestimated in clinical practice: impact of a dedicated screening approach at a large university teaching hospital.
Marjot T; Sbardella E; Moolla A; Hazlehurst JM; Tan GD; Ainsworth M; Cobbold JFL; Tomlinson JW
Diabet Med; 2018 Jan; 35(1):89-98. PubMed ID: 29094442
[TBL] [Abstract][Full Text] [Related]
20. Awareness of non-alcoholic steatohepatitis and treatment guidelines: What are physicians telling us?
Wessels DH; Rosenberg Z
World J Hepatol; 2021 Feb; 13(2):233-241. PubMed ID: 33708352
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
